Aurelie Brelin

Title: Innovations by Aurelie Brelin in Bioactive Molecules

Introduction

Aurelie Brelin is an accomplished inventor based in Basel, Switzerland. She has made significant contributions to the field of bioactive molecules, particularly in the development of fusion proteins that enhance feed utilization in animals. Her innovative work has the potential to improve agricultural practices and animal husbandry.

Latest Patents

Aurelie Brelin holds a patent for the "Fusion of bioactive molecules." This patent describes fusion proteins containing an enzyme, preferably a feed or food enzyme, coupled to a gut surface-binding domain. These fusion proteins are designed to promote feed utilization in animals. A notable example includes a fusion enzyme that comprises a gut-surface-binding polypeptide segment linked to a phytase. This innovation results in an increased resident time in the gut, allowing the enzyme more time to catalyze reactions that ultimately lead to improved feed utilization. She has 1 patent to her name.

Career Highlights

Aurelie Brelin is currently employed at Novozymes A/S, a company renowned for its focus on biological solutions. Her work at Novozymes has allowed her to explore the intersection of biotechnology and agriculture, leading to advancements that benefit both animals and the environment.

Collaborations

Throughout her career, Aurelie has collaborated with notable colleagues, including Ghislain Schyns and Stephane Duval. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Aurelie Brelin's contributions to the field of bioactive molecules exemplify the impact of innovative thinking in agriculture. Her patent on fusion proteins highlights the potential for scientific advancements to improve feed utilization in animals. Her work continues to inspire future innovations in biotechnology.